RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Star Combo Pharma - Stock

Star Combo Pharma ROA 2024

Star Combo Pharma ROA

-0.09

Ticker

S66.AX

ISIN

AU0000004798

In 2024, Star Combo Pharma's return on assets (ROA) was -0.09, a 491.41% increase from the -0.02 ROA in the previous year.

Star Combo Pharma Aktienanalyse

What does Star Combo Pharma do?

Star Combo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Star Combo Pharma's Return on Assets (ROA)

Star Combo Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Star Combo Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Star Combo Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Star Combo Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Star Combo Pharma Stock

What is the Return on Assets (ROA) of Star Combo Pharma this year?

The Return on Assets (ROA) of Star Combo Pharma is -0.09 undefined this year.

What was the ROA of Star Combo Pharma compared to the previous year?

The ROA of Star Combo Pharma has increased by 491.41% compared to the previous year.

What consequences do high ROA have for investors of Star Combo Pharma?

A high ROA is advantageous for investors of Star Combo Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Star Combo Pharma?

A low ROA can be unfavorable for investors of Star Combo Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Star Combo Pharma affect the company?

An increase in ROA of Star Combo Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Star Combo Pharma impact the company?

A reduction in the ROA of Star Combo Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Star Combo Pharma?

Some factors that can influence the ROA of Star Combo Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Star Combo Pharma important for investors?

The ROA of Star Combo Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Star Combo Pharma take to improve ROA?

To improve ROA, Star Combo Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Star Combo Pharma pay?

Over the past 12 months, Star Combo Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Star Combo Pharma is expected to pay a dividend of 0 AUD.

What is the dividend yield of Star Combo Pharma?

The current dividend yield of Star Combo Pharma is .

When does Star Combo Pharma pay dividends?

Star Combo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Star Combo Pharma?

Star Combo Pharma paid dividends every year for the past 0 years.

What is the dividend of Star Combo Pharma?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Star Combo Pharma located?

Star Combo Pharma is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Star Combo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Star Combo Pharma from 7/1/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Star Combo Pharma pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Star Combo Pharma in the year 2023?

In the year 2023, Star Combo Pharma distributed 0 AUD as dividends.

In which currency does Star Combo Pharma pay out the dividend?

The dividends of Star Combo Pharma are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Star Combo Pharma

Our stock analysis for Star Combo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Star Combo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.